Editing CUA: Follow-up Localized RCC (2018) (section)

== Surveillance Schedule Post-Surgical Resection ==
* '''See [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114161/table/t1-cuaj-8-231/ Table 1] from Original Guideline for Surveillance Schedule'''
* '''Blood tests include: CBC, serum chemistries, Cr, LFTs'''
* '''If patient is symptomatic or abnormal blood test, earlier radiological investigations may be indicated'''
* '''Low-risk (pT1)'''
** '''Abdominal CT, MRI, or US is recommended at 24 and 60 months'''
*** US is less sensitive than CT, however, its use is justifiable and cost-effective in patients with a minimal risk of abdominal recurrence and lower body mass index (BMI).
** '''Follow-up is the same for PN for lesions <4 cm,''' since local recurrence rates in this population are similar to RN
*** '''CT abdomen at 3–12 months postoperative for patients treated with PN to evaluate the residual baseline renal appearance is optional'''
** '''Routine imaging beyond 5 years is optional and can be risk-adapted'''
* '''Intermediate-risk (pT2)'''
** '''Abdominal CT, MRI, or US recommended at 12, 24, 36, and 60 months'''
** '''Routine imaging beyond 5 years is at the discretion of the treating physician'''
* '''High-risk (pT3-4)'''
** '''Abdominal CT or MRI is recommended at 6, 12, 18, 24, 36, and 60 months, then every 2 years'''
* '''Very high-risk (N+)'''
** '''Abdominal CT or MRI is recommended at 3 and 6 months, then every 6 months for 3 years, then yearly'''